increased B cell derived lymphoma incidence_Bcl2<tm2.1Lbox>/Bcl2<+>

http://metadb.riken.jp/0002023I129S1Sv129X1SvJFVBNBcl2tm21LboxBcl2Bcl2Bcl2tm21Lbox

increased B cell derived lymphoma incidence_Bcl2<tm2.1Lbox>/Bcl2<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• B cell leukemia/lymphoma 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:88138

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Bcl2<tm2.1Lbox>/Bcl2<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Bcl2<+>|Bcl2<tm2.1Lbox>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * 129X1/SvJ * FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased B cell derived lymphoma incidence
  http://purl.obolibrary.org/obo/MP_0002023

文献

http://purl.org/net/cito/citesAsAuthority

• H. Xiang, et.al., The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells., Leukemia, 2011, 25
  http://rdf.ncbi.nlm.nih.gov/pubmed/21606958